mk 0663 has been researched along with bromodeoxyuridine in 1 studies
Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) | Studies (bromodeoxyuridine) | Trials (bromodeoxyuridine) | Recent Studies (post-2010) (bromodeoxyuridine) |
---|---|---|---|---|---|
549 | 173 | 265 | 13,164 | 71 | 1,816 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Piplani, H; Sanyal, S; Tanwar, L | 1 |
1 other study(ies) available for mk 0663 and bromodeoxyuridine
Article | Year |
---|---|
Anti-proliferative and apoptotic effects of etoricoxib, a selective COX-2 inhibitor, on 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Colon; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; DNA Fragmentation; Etoricoxib; Male; Proliferating Cell Nuclear Antigen; Pyridines; Rats; Rats, Sprague-Dawley; Sulfones | 2010 |